Search
Feed aggregator
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome 4/16/2024
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit 4/16/2024
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf...
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf... 4/15/2024
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion 4/15/2024
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer 4/15/2024
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment 4/15/2024
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune 4/15/2024
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech 4/15/2024
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development 4/15/2024
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra 4/15/2024
4 Investigational Weight Loss Drugs That Could Change the Market
4 Investigational Weight Loss Drugs That Could Change the Market 4/15/2024
World Pharma News
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
- Life-changing drug identified for children with rare epilepsy
- Pfizer's Phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis
- People with COPD commonly misuse medications
- Chemically ‘stapled’ peptides used to target difficult-to-treat cancers